SVA

Sinovac Biotech, Ltd.

USD

Set alert

Price alert · SVA

All alert types
6.47 USD 0.00 0.00%
As of Oct 28, 2026

Day range unavailable

6.47 52-week range 6.47
YTD
0.00%
1 year
0.00%
Open
—
Prev close
6.47
Mkt cap
642.44M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-53.92
Beta
0.00
Dividend
0.00
Ex-div date
50-d avg
6.47
200-d avg
6.47
1y target
3.52

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SVA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -7.8×
FY 2016: -562×FY 2017: 17.8×FY 2018: 20.4×FY 2019: 15.4×FY 2020: 6.1×FY 2021: 0.1×FY 2022: 6.0×FY 2023: -6.1×FY 2024: 5.1×FY 2025: -7.8×
FY 2016 5y median 0.1× FY 2025
P/S 1.2×
FY 2016: 4.6×FY 2017: 2.6×FY 2018: 2.0×FY 2019: 2.5×FY 2020: 1.3×FY 2021: 0.0×FY 2022: 0.4×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
P/B 0.1×
FY 2016: 2.9×FY 2017: 3.0×FY 2018: 1.8×FY 2019: 2.1×FY 2020: 0.9×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
P/FCF -0.8×
FY 2016: -12.7×FY 2017: 9.6×FY 2018: 193×FY 2019: 21.6×FY 2020: 1.8×FY 2021: 0.0×FY 2022: -0.5×FY 2023: -15.5×FY 2024: -3.0×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
EV/EBITDA 1.0×
FY 2016: 47.6×FY 2017: 7.5×FY 2018: 5.8×FY 2019: 6.3×FY 2020: -1.2×FY 2021: -0.6×FY 2022: -19.4×FY 2023: 54.2×FY 2024: -1.4×FY 2025: 1.0×
FY 2016 5y median -0.6× FY 2025
EV/Sales -0.5×
FY 2016: 4.4×FY 2017: 2.2×FY 2018: 1.3×FY 2019: 2.0×FY 2020: -0.5×FY 2021: -0.6×FY 2022: -2.4×FY 2023: -0.7×FY 2024: 1.4×FY 2025: -0.5×
FY 2016 5y median -0.6× FY 2025
FCF Yield -120.3%
FY 2016: -7.9%FY 2017: 10.5%FY 2018: 0.5%FY 2019: 4.6%FY 2020: 55.0%FY 2021: 2277.3%FY 2022: -182.4%FY 2023: -6.5%FY 2024: -32.9%FY 2025: -120.3%
FY 2016 5y median -32.9% FY 2025

Profitability

Gross Margin 67.9%
FY 2016: 69.1%FY 2017: 88.4%FY 2018: 89.2%FY 2019: 86.8%FY 2020: 86.8%FY 2021: 94.5%FY 2022: 54.1%FY 2023: 59.5%FY 2024: 61.1%FY 2025: 67.9%
FY 2016 5y median 61.1% FY 2025
Operating Margin -75.5%
FY 2016: 0.7%FY 2017: 26.0%FY 2018: 19.7%FY 2019: 27.9%FY 2020: 42.2%FY 2021: 90.6%FY 2022: -31.2%FY 2023: -122.0%FY 2024: -133.7%FY 2025: -75.5%
FY 2016 5y median -75.5% FY 2025
Net Margin -15.5%
FY 2016: -0.8%FY 2017: 14.8%FY 2018: 9.5%FY 2019: 18.3%FY 2020: 21.6%FY 2021: 43.7%FY 2022: 7.6%FY 2023: -22.3%FY 2024: 25.2%FY 2025: -15.5%
FY 2016 5y median 7.6% FY 2025
ROE -1.3%
FY 2016: -0.5%FY 2017: 17.1%FY 2018: 8.6%FY 2019: 15.3%FY 2020: 14.8%FY 2021: 90.8%FY 2022: 1.3%FY 2023: -1.1%FY 2024: 1.1%FY 2025: -1.3%
FY 2016 5y median 1.1% FY 2025
ROIC -3.0%
FY 2016: 0.3%FY 2017: 16.5%FY 2018: 11.2%FY 2019: 16.7%FY 2020: 14.6%FY 2021: 100.7%FY 2022: -3.6%FY 2023: -4.3%FY 2024: -4.1%FY 2025: -3.0%
FY 2016 5y median -3.6% FY 2025
ROA -0.7%
FY 2016: -0.3%FY 2017: 8.6%FY 2018: 5.9%FY 2019: 9.9%FY 2020: 5.8%FY 2021: 50.6%FY 2022: 0.8%FY 2023: -0.7%FY 2024: 0.7%FY 2025: -0.7%
FY 2016 5y median 0.7% FY 2025

Growth (YoY)

Revenue 6.8%
FY 2016: 7.4%FY 2017: 140.7%FY 2018: 31.7%FY 2019: 7.1%FY 2020: 107.5%FY 2021: 3694.4%FY 2022: -92.3%FY 2023: -70.0%FY 2024: -19.4%FY 2025: 6.8%
FY 2016 FY 2025
Operating Income 39.7%
FY 2016: -86.4%FY 2017: 8911.3%FY 2018: -0.2%FY 2019: 51.3%FY 2020: 214.5%FY 2021: 8039.9%FY 2022: -102.7%FY 2023: -17.3%FY 2024: 11.6%FY 2025: 39.7%
FY 2016 FY 2025
EPS (diluted) -165.9%
FY 2016: 58.2%FY 2017: 4385.7%FY 2018: -24.4%FY 2019: 20.6%FY 2020: 136.6%FY 2021: 7556.7%FY 2022: -98.7%FY 2023: -206.0%FY 2024: 218.9%FY 2025: -165.9%
FY 2016 FY 2025
Free Cash Flow -266.0%
FY 2016: -2340.8%FY 2017: 280.2%FY 2018: -95.1%FY 2019: 1120.9%FY 2020: 1136.2%FY 2021: 4061.0%FY 2022: -108.0%FY 2023: 96.4%FY 2024: -266.6%FY 2025: -266.0%
FY 2016 FY 2025

Financial Health

Current Ratio 4.6×
FY 2016: 2.0×FY 2017: 2.2×FY 2018: 4.9×FY 2019: 4.0×FY 2020: 2.3×FY 2021: 6.2×FY 2022: 11.1×FY 2023: 10.3×FY 2024: 7.3×FY 2025: 4.6×
FY 2016 5y median 7.3× FY 2025
Quick Ratio 4.5×
FY 2016: 1.8×FY 2017: 2.0×FY 2018: 4.5×FY 2019: 3.7×FY 2020: 2.1×FY 2021: 6.0×FY 2022: 10.9×FY 2023: 10.2×FY 2024: 7.3×FY 2025: 4.5×
FY 2016 5y median 7.3× FY 2025
Debt / Equity 0.1×
FY 2016: 0.4×FY 2017: 0.3×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.2×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 3.5×
FY 2016: -2.9×FY 2017: -1.5×FY 2018: -2.7×FY 2019: -1.7×FY 2020: -4.1×FY 2021: -0.6×FY 2022: -23.0×FY 2023: 161×FY 2024: -0.2×FY 2025: 3.5×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -29.7×
FY 2016: 0.3×FY 2017: 28.9×FY 2018: 42.4×FY 2019: 105×FY 2020: 148×FY 2021: 6189×FY 2022: -369×FY 2023: -242×FY 2024: -85.7×FY 2025: -29.7×
FY 2016 5y median -85.7× FY 2025

Dividends

Dividend Yield 755.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 291.9%FY 2022: 40.9%FY 2023: 50.9%FY 2024: 203.7%FY 2025: 755.7%
FY 2016 5y median 203.7% FY 2025
Payout Ratio -5887.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 22.2%FY 2022: 231.1%FY 2023: -328.3%FY 2024: 1041.7%FY 2025: -5887.2%
FY 2016 5y median 22.2% FY 2025

Annual · latest fiscal year ends 2025-12-31